{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:44:28Z","timestamp":1792179868794,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asia-Pacific Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.apjo.2024.100122","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:52:43Z","timestamp":1733532763000},"page":"100122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Low-concentration atropine for controlling myopia onset and progression in East Asia"],"prefix":"10.1016","volume":"13","author":[{"given":"Ebenezer","family":"Zaabaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Wai","family":"Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement C.","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Pui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apjo.2024.100122_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41572-020-00231-4","article-title":"Myopia","volume":"6","author":"Baird","year":"2020","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.apjo.2024.100122_bib2","first-page":"243","article-title":"The role of myopia in 2020 uncorrected global visual impairment","volume":"63","author":"Jong","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100122_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42108-y","article-title":"The underestimated role of myopia in uncorrectable visual impairment in the United States","volume":"13","author":"Bullimore","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.apjo.2024.100122_bib4","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/d41586-024-01518-2","article-title":"A myopia epidemic is sweeping the globe. Here's how to stop it","volume":"629","author":"Dolgin","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.apjo.2024.100122_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/519276a","article-title":"The myopia boom","volume":"519","author":"Dolgin","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.apjo.2024.100122_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/APO.0000000000000568","article-title":"Prevalence and risk factors of refractive errors and effective spectacle coverage in Emiratis and Non-Emiratis aged 40 years or older: the Dubai Eye Health Survey","volume":"12","author":"Rabiu","year":"2023","journal-title":"Asia Pac J Ophthalmol (Philos)"},{"key":"10.1016\/j.apjo.2024.100122_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bjo-2024-325427","article-title":"Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis","author":"Liang","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib8","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1167\/iovs.61.4.49","article-title":"The complications of myopia: a review and meta-analysis","volume":"61","author":"Haarman","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100122_bib10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/APO.0000000000000236","article-title":"Epidemiology of myopia","volume":"5","author":"Wu","year":"2016","journal-title":"Asia Pac J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaophthalmol.2023.6319","article-title":"Four-year progression of myopic maculopathy in children and adolescents with high myopia","volume":"142","author":"Jiang","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib12","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s10792-021-01834-w","article-title":"Pediatric rhegmatogenous retinal detachment: predictors of anatomic and functional success","volume":"41","author":"Carranza-Casas","year":"2021","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/APO.0000000000000609","article-title":"Atropine ophthalmic solution to reduce myopia progression in pediatric subjects: the randomized, double-blind multicenter phase II APPLE study","volume":"12","author":"Chia","year":"2023","journal-title":"Asia Pac J Ophthalmol (Philos)"},{"key":"10.1016\/j.apjo.2024.100122_bib14","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ophtha.2008.10.020","article-title":"Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine","volume":"116","author":"Tong","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on Atropine for the Treatment of Myopia 2: myopia control with atropine 0.01% eye drops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/jamaophthalmol.2017.6638","article-title":"Low-dose atropine for myopia control: considering all the data","volume":"136","author":"Bullimore","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib19","series-title":"The impact of myopia and high myopia: report of the Joint World Health Organization-Brien Holden Vision Institute Global Scientific Meeting on Myopia","author":"Myopia","year":"2015"},{"key":"10.1016\/j.apjo.2024.100122_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/cxo.12967","article-title":"Which low-dose atropine for myopia control?","volume":"103","author":"Khanal","year":"2020","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.apjo.2024.100122_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaapos.2018.07.268","article-title":"Current trends to decrease myopia progression survey: an IPOSC global study","volume":"22","author":"Mezer","year":"2018","journal-title":"J AAPOS"},{"key":"10.1016\/j.apjo.2024.100122_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/ijo.IJO_1457_18","article-title":"Consensus statement and guidelines for use of dilute atropine sulphate in myopia control","volume":"67","author":"Kesarwani","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib24","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ophtha.2020.06.004","article-title":"Differential effects on ocular biometrics by 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression study","volume":"127","author":"Li","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib25","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/OPX.0000000000000037","article-title":"Maximum atropine dose without clinical signs or symptoms","volume":"90","author":"Cooper","year":"2013","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.apjo.2024.100122_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69710-8","article-title":"Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial","volume":"10","author":"Kinoshita","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.apjo.2024.100122_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2022.101723","article-title":"Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: a 2-year randomized clinical trial","volume":"46","author":"Tan","year":"2023","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.apjo.2024.100122_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2024.102317","article-title":"Effect of 0.01% atropine eye drops combined with different optical treatments to control low myopia in Chinese children","author":"Cao","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.apjo.2024.100122_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bjo-2023-323887","article-title":"Advances in myopia control strategies for children","author":"Zhang","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ophtha.2018.11.026","article-title":"Use of orthokeratology for the prevention of myopic progression in children: a report by the American Academy of","volume":"126","author":"VanderVeen","year":"2019","journal-title":"Ophthalmol Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib31","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-year clinical trial of the Low-concentration Atropine for Myopia Progression (LAMP) study: phase 2 report","volume":"127","author":"Yam","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib32","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.ophtha.2020.12.036","article-title":"Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression study","volume":"128","author":"Li","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2021.12.014","article-title":"The association of choroidal thickening by atropine with treatment effects for myopia: two-year clinical trial of the Low-concentration Atropine for Myopia Progression (LAMP) study","volume":"237","author":"Yam","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","article-title":"Three-year clinical trial of Low-concentration Atropine for Myopia Progression (LAMP) study: continued versus washout: phase 3 report","volume":"129","author":"Yam","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2024.03.013","article-title":"Five-year clinical trial of the Low-concentration Atropine for Myopia Progression (LAMP) study: phase 4 report","author":"Zhang","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib36","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.2022.24162","article-title":"Effect of low-concentration atropine eye drops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial","volume":"329","author":"Yam","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.apjo.2024.100122_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.9612","article-title":"Effect of repeated low-level red light on myopia prevention among children in China with premyopia: a randomized clinical trial","volume":"6","author":"He","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.apjo.2024.100122_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/aos.13403","article-title":"Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review","volume":"95","author":"Xiong","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib39","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ophtha.2012.11.009","article-title":"Outdoor activity during class recess reduces myopia onset and progression in school children","volume":"120","author":"Wu","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib40","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ophtha.2024.06.010","article-title":"Hyperopic reserve as an indicator of myopia prevention by atropine (Low-concentration Atropine for Myopia Prevention study)","volume":"131","author":"Zhang","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jamaophthalmol.2023.5467","article-title":"Topical atropine for childhood myopia control: the Atropine Treatment Long-term Assessment Study","volume":"142","author":"Li","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/OPX.0b013e3182357f79","article-title":"Myopia progression rates in urban children wearing single-vision spectacles","volume":"89","author":"Donovan","year":"2012","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.apjo.2024.100122_bib43","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/opo.13159","article-title":"Normative data for axial elongation in Asian children","volume":"43","author":"Naduvilath","year":"2023","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.apjo.2024.100122_bib44","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ophtha.2007.12.019","article-title":"Outdoor activity reduces the prevalence of myopia in children","volume":"115","author":"Rose","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/aos.14942","article-title":"Near work, screen time, outdoor time and myopia in schoolchildren in the sunflower myopia AEEC consortium","volume":"100","author":"Lanca","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/cxo.12346","article-title":"A review of environmental risk factors for myopia during early life, childhood and adolescence","volume":"98","author":"Ramamurthy","year":"2015","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.apjo.2024.100122_bib47","first-page":"1542","article-title":"Objectively measured near work, outdoor exposure and myopia in children","volume":"104","author":"Wen","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib48","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/bjophthalmol-2019-314101","article-title":"Protective behaviours of near work and time outdoors in myopia prevalence and progression in myopic children: a 2-year prospective population study","volume":"104","author":"Huang","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.43781","article-title":"Evaluation of an optical defocus treatment for myopia progression among schoolchildren during the COVID-19 pandemic","volume":"5","author":"Choi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.apjo.2024.100122_bib50","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1111\/aos.15761","article-title":"Myopia outcome study of atropine in children: two-year result of daily 0.01% atropine in a European population","volume":"102","author":"Loughman","year":"2024","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"10.1016\/j.apjo.2024.100122_bib51","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.ophtha.2020.01.054","article-title":"Increased time outdoors is followed by reversal of the long-term trend to reduced visual acuity in Taiwan primary school students","volume":"127","author":"Wu","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2024.100122_bib52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jesf.2018.10.005","article-title":"Results from the Chinese Taipei (Taiwan) 2018 report card on physical activity for children and youth","volume":"17","author":"Wu","year":"2019","journal-title":"J Exerc Sci Fit"},{"key":"10.1016\/j.apjo.2024.100122_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/APO.0000000000000489","article-title":"China turns to school reform to control the myopia epidemic: a narrative review","volume":"11","author":"Morgan","year":"2022","journal-title":"Asia Pac J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib54","first-page":"129","article-title":"Effect of outdoor scene classrooms on myopia prevention and control: one-year result from a randomized clinical trial","volume":"65","author":"Lan","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100122_bib55","series-title":"Critical care toxicology","first-page":"2725","article-title":"Atropine","author":"French","year":"2017"},{"key":"10.1016\/j.apjo.2024.100122_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1475-1313.1995.9500074n.x","article-title":"Pirenzepine prevents form deprivation myopia in a dose dependent manner","volume":"15","author":"Leech","year":"1995","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.apjo.2024.100122_bib57","first-page":"205","article-title":"Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism","volume":"34","author":"McBrien","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100122_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0952523800002327","article-title":"Developing eyes that lack accommodation grow to compensate For imposed defocus","volume":"4","author":"Schaeffel","year":"1990","journal-title":"Vis Neurosci"},{"key":"10.1016\/j.apjo.2024.100122_bib59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/ICL.0000000000000677","article-title":"Biological mechanisms of atropine control of myopia","volume":"46","author":"Upadhyay","year":"2020","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.apjo.2024.100122_bib60","first-page":"3342","article-title":"M4 muscarinic acetylcholine receptors mediate muscarinic block of axial elongation in the chicken","volume":"46","author":"Morgan","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100122_bib61","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/opo.12052","article-title":"How does atropine exert its anti-myopia effects?","volume":"33","author":"McBrien","year":"2013","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.apjo.2024.100122_bib62","first-page":"2217","article-title":"Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes","volume":"39","author":"Lind","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100122_bib63","first-page":"639","article-title":"Alterations in ZENK and glucagon RNA transcript expression during increased ocular growth in chickens","volume":"16","author":"Ashby","year":"2010","journal-title":"Mol Vis"},{"key":"10.1016\/j.apjo.2024.100122_bib64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.exer.2007.02.019","article-title":"A muscarinic cholinergic antagonist and a dopamine agonist rapidly increase ZENK mRNA expression in the form-deprived chicken retina","volume":"85","author":"Ashby","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.apjo.2024.100122_bib65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/opo.12054","article-title":"Effects of muscarinic agents on chick choroids in intact eyes and eyecups: evidence for a muscarinic mechanism in choroidal thinning","volume":"33","author":"Nickla","year":"2013","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.apjo.2024.100122_bib66","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8528315","article-title":"Effect of atropine eye drops on choroidal thinning induced by hyperopic retinal defocus","volume":"2018","author":"Chiang","year":"2018","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.64.6.3","article-title":"IMI - Management and investigation of high myopia in infants and young children","volume":"64","author":"Flitcroft","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100122_bib68","doi-asserted-by":"crossref","first-page":"M89","DOI":"10.1167\/iovs.18-25965","article-title":"IMI - Myopia genetics report","volume":"60","author":"Tedja","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2024.100122_bib69","doi-asserted-by":"crossref","DOI":"10.1136\/bjo-2024-325606","article-title":"Associations of genetic variants for refractive error and axial length in adults with ocular endophenotypes in children: a cross-sectional and longitudinal study","author":"Zaabaar","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2024.100122_bib70","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1167\/iovs.17-22173","article-title":"CREAM Consortium. Novel myopia genes and pathways identified from syndromic forms of myopia","volume":"59","author":"Flitcroft","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Asia-Pacific Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162098924001427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162098924001427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T01:48:11Z","timestamp":1734659291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162098924001427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2162098924001427"],"URL":"https:\/\/doi.org\/10.1016\/j.apjo.2024.100122","relation":{},"ISSN":["2162-0989"],"issn-type":[{"value":"2162-0989","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-concentration atropine for controlling myopia onset and progression in East Asia","name":"articletitle","label":"Article Title"},{"value":"Asia-Pacific Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apjo.2024.100122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of Asia-Pacific Academy of Ophthalmology and Academy of Asia-Pacific Professors of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100122"}}